Low molecular weight inhibitors in corneal ulceration

Ann N Y Acad Sci. 1994 Sep 6:732:315-23. doi: 10.1111/j.1749-6632.1994.tb24746.x.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase I
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Burns, Chemical / complications
  • Corneal Ulcer / etiology
  • Corneal Ulcer / prevention & control*
  • Dipeptides / pharmacology*
  • Dipeptides / therapeutic use
  • Dipeptides / toxicity*
  • Eye Infections / complications
  • Gingiva / enzymology
  • Humans
  • Inflammation
  • Matrix Metalloproteinase 8
  • Matrix Metalloproteinase Inhibitors
  • Metalloendopeptidases / antagonists & inhibitors*
  • Mice
  • Peritonitis / chemically induced
  • Peritonitis / prevention & control
  • Phorbol 12,13-Dibutyrate / pharmacology
  • Pseudomonas Infections / complications
  • Rabbits
  • Reference Values
  • Skin / enzymology
  • Skin Diseases / chemically induced
  • Skin Diseases / pathology
  • Skin Diseases / prevention & control
  • Thioglycolates

Substances

  • Dipeptides
  • Matrix Metalloproteinase Inhibitors
  • N-(2(R)-2-(hydroxamidocarbonylmethyl)-4-methylpentanoyl)-L-tryptophan methylamide
  • Thioglycolates
  • Phorbol 12,13-Dibutyrate
  • Metalloendopeptidases
  • Matrix Metalloproteinase 8